S&P Pharmaceuticals SPDR (XPH)

$43.81 0.44 (0.99%)

20:00 EST XPH Stock Quote Delayed 30 Minutes

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

7 Pharmaceutical Stocks to Buy for 2021 and Beyond

Apellis is Outperforming the Pharmaceutical Sector

Use Johnson & Johnson for Quick Income

More Articles

Volume:

Previous Close -

Market Cap 2.10M

PE Ratio -

EPS -

Volume (Avg. Vol.) 18,448

Day's Range $43.75 - $44.25

52-Week Range $37.94 - $46.61

Dividend & Yield N/A (N/A)

XPH Stock Predictions, Articles, and S&P Pharmaceuticals SPDR News

From InvestorPlace
From the Web

Collect on the Pharmaceutical Boom With Eli Lilly

By Ken Trester Dec 17, 2019

Eli Lilly and Company (NYSE:LLY) provided optimistic guidance for 2020 today, and it looks like the stock will head higher at the open this morning.

3 Healthcare ETFs to Sell Amid Political Headwinds

By Todd Shriber, InvestorPlace Contributor Apr 23, 2019

While the rest of the market continues upward, the healthcare sector -- and healthcare ETFs -- continue to struggle.

5 Best-Performing Sector ETFs of July

By Zacks Investment Research Aug 2, 2018

We have highlighted sector ETFs that witnessed handsome gains last month and could be better plays in the months ahead should the trends prevail. Compare Broker....

7 Best Healthcare ETFs for the Rest of 2018

By Todd Shriber, InvestorPlace Contributor Mar 8, 2018

Some of the best healthcare ETFs to buy are more "traditional", while others focus on very specific areas of the industry. These seven healthcare ETFs should deliver for investors over the remainder of 2018.

What Lies in Store for Pharma ETFs?

By Zacks Investment Research Nov 27, 2017

Pharma stocks have done well this year; what lies ahead?

When You Exit the Market, Don’t Let The Door Hit You On Your Way Out

By Gary Gordon, President, Pacific Park Financial May 18, 2016

You cannot make this stuff up. The median stock in the S&P 500 has never been more overvalued on these key metrics. Now's the time for caution...

3 “Happy New Year” ETFs to Buy for Huge Growth

By Johnson Research Group Dec 22, 2015

Unwarranted bearishness and strong technicals make these three ETFs good bets for the New Year.

3 Pharma Stocks Yielding Over 3%

From Talk Markets Jan 18, 2022

The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries.

The Bear Market Is Already Here – But Not For Dividend Investors

From Talk Markets Dec 22, 2021

While the broad stock market indices remain at near-record levels, there are sectors of the market that have dropped into correction or even bear market territory over recent months.

Wave of Solid Q3 Earnings Push Pharma ETFs Higher

From Talk Markets Nov 9, 2021

The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.

The Cost Of Saving The Economy: $1.7 Billion Per Hour Every Hour

From Talk Markets Aug 20, 2021

the Fed has bought $4 trillion bonds in the past 18 months, twice the amount the US spent on War in Afghanistan past 20 years as it, and other global central banks, have spent $834 million every hour buying bonds since COVID.

3 Pharma Stocks with Tremendous Growth Potential

From StockNews.com Jun 30, 2021

Growing optimism over the pharmaceutical industry’s growth prospects amid the COVID-19 pandemic has bolstered the performance of certain dominant pharma players. As pharma companies continue to invest heavily in drug development to capitalize on rising demand from an aging population, they are well positioned to achieve extraordinary growth going forward. Given the tremendous growth potential of Johnson & Johnson (JNJ), Pfizer (PFE), and Bristol-Myers Squibb (BMY), we think these stocks could be solid bets now. So, let’s take a closer look at these names.

3 Top Pharma Stocks to Buy This Month

From Talk Markets Jun 9, 2021

In 2020, pharmaceutical stocks came to the forefront as healthcare companies were searching for treatments for COVID-19.